Announcements
- Key Figures 15.02.2026
- Key Figures 31.01.2026
- HBM Healthcare Investments publishes Quarterly Report as at 31 December 2025 with key figures for the first nine months of the 2025/2026 financial year
- Key Figures 15.01.2026
- HBM Healthcare Investments once again delivered strong value growth in the 2025 calendar year despite currency headwind
- Key Figures 31.12.2025
- Key Figures 15.12.2025
- HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma
- Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
- Key Figures 30.11.2025
More ▼
Key statistics
On Monday, HBM Healthcare Investments AG (HBMN:SWX) closed at 220.50, -10.18% below its 52-week high of 245.50, set on Jan 27, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 6.74m |
|---|---|
| Market cap | 1.53bn CHF |
| Total assets | 1.90bn CHF |
| Total expense ratio | -- |
| High | 223.00 |
| Low | 219.50 |
| Previous close | 220.00 |
| Average volume | 6.50k |
|---|---|
| YTD Change | -2.65% |
| Beta | 0.9507 |
| Diluted NAV (est) | 280.13 |
| Diluted NAV (last pub) | 272.51 |
| Premium/Discount | -- |
| Net Gearing | 0.00% |
| Annual div (ADY) | 7.50 CHF |
|---|---|
| Annual div yield (ADY) | 3.41% |
| Div ex-date | Jul 02 2025 |
| Div pay-date | Jul 04 2025 |
Data delayed at least 15 minutes, as of Feb 16 2026 16:31 GMT.
More ▼
